Malaysia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Malaysia

The Malaysian medicaments containing hormones market rose significantly to $X in 2022, increasing by X% against the previous year. Overall, consumption posted a prominent increase. Over the period under review, the market attained the maximum level at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Malaysia

In value terms, medicaments containing hormones production rose sharply to $X in 2022 estimated in export price. In general, production recorded buoyant growth. The growth pace was the most rapid in 2014 when the production volume increased by X% against the previous year. Over the period under review, production attained the peak level at $X in 2015; however, from 2016 to 2022, production stood at a somewhat lower figure.

Medicaments Containing Hormones Exports

Exports from Malaysia

In 2022, the amount of medicaments containing hormones but not antibiotics exported from Malaysia fell dramatically to X tons, shrinking by X% compared with 2021. Overall, exports saw a abrupt downturn. The growth pace was the most rapid in 2014 when exports increased by X% against the previous year. Over the period under review, the exports hit record highs at X tons in 2015; however, from 2016 to 2022, the exports remained at a lower figure.

In value terms, medicaments containing hormones exports contracted rapidly to $X in 2022. In general, exports showed a deep reduction. The growth pace was the most rapid in 2014 when exports increased by X% against the previous year. The exports peaked at $X in 2015; however, from 2016 to 2022, the exports failed to regain momentum.

Exports by Country

Singapore (X tons) was the main destination for medicaments containing hormones exports from Malaysia, with a X% share of total exports. It was followed by the Netherlands (X kg), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Singapore stood at X%.

In value terms, Singapore ($X) remains the key foreign market for medicaments containing hormones but not antibiotics exports from Malaysia, comprising X% of total exports. The second position in the ranking was held by the Netherlands ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value to Singapore totaled X%.

Export Prices by Country

In 2022, the average medicaments containing hormones export price amounted to $X per ton, remaining stable against the previous year. In general, the export price, however, saw a noticeable reduction. The pace of growth appeared the most rapid in 2019 when the average export price increased by X%. Over the period under review, the average export prices attained the peak figure at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while the average price for exports to Singapore stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Singapore (X%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Hormones Imports

Imports into Malaysia

In 2022, overseas purchases of medicaments containing hormones but not antibiotics decreased by X% to X tons, falling for the second consecutive year after two years of growth. Overall, imports recorded a perceptible contraction. The pace of growth appeared the most rapid in 2019 when imports increased by X%. Imports peaked at X tons in 2014; however, from 2015 to 2022, imports failed to regain momentum.

In value terms, medicaments containing hormones imports soared to $X in 2022. In general, imports showed a deep downturn. The pace of growth appeared the most rapid in 2013 when imports increased by X%. As a result, imports attained the peak of $X. From 2014 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2022, Cyprus (X tons) constituted the largest supplier of medicaments containing hormones to Malaysia, accounting for a X% share of total imports. Moreover, medicaments containing hormones imports from Cyprus exceeded the figures recorded by the second-largest supplier, Italy (X tons), eightfold. Singapore (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Cyprus stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (X% per year) and Singapore (X% per year).

In value terms, Cyprus ($X), Italy ($X) and India ($X) appeared to be the largest medicaments containing hormones suppliers to Malaysia, together accounting for X% of total imports. Singapore, Germany and Pakistan lagged somewhat behind, together comprising a further X%.

Among the main suppliers, Pakistan, with a CAGR of X%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

The average medicaments containing hormones import price stood at $X per ton in 2022, jumping by X% against the previous year. In general, the import price, however, continues to indicate a deep setback. The pace of growth was the most pronounced in 2018 an increase of X% against the previous year. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Italy ($X per ton), while the price for Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :